Michele Solis

A cloud of doubt over the sunshine vitaminSubscription

9 JAN 2020

Negative results in trials of vitamin D supplementation have led researchers to question the best way of reaching those who are deficient.

Fish oils for cardiovascular disease: a turning point?Subscription

10 MAY 2019

The use of fish oils to improve cardiovascular health has been in and out of favour for decades, but positive results from a recent trial of Amarin’s Vascepa have created quite a stir — particularly as they come after a set of negative findings in 2018.

Personalised treatment for depression on the horizon: predicting response to antidepressantsSubscription

6 OCT 2016Comments (1)

Only one-third of patients with depression benefit from the first antidepressant they try, but researchers are striving to find biological features that predict how a person will respond to particular drugs so they can tailor treatment from the beginning.

Cannabis for epilepsy: is there enough evidence of efficacy?

10 JAN 2017

Back to basics: striving to stall Parkinson’s disease progressionSubscription

21 SEP 2017

Tipping the scales: the problem of drug dosing in obese patientsSubscription

19 OCT 2018Comments (1)

Heroin abuse: breaking the cycleSubscription

25 JUN 2015

Coeliac disease: getting the measure of new drug treatmentsSubscription

13 NOV 2015

Why the use of anti-ageing drugs could delay the development of chronic diseasesSubscription

11 FEB 2016

Autism: in search of new drug targetsSubscription

21 APR 2016